Renal clearance of oxipurinol, the chief metabolite of allopurinol
- 31 July 1968
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 45 (1) , 69-77
- https://doi.org/10.1016/0002-9343(68)90008-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Treatment of Gout with Allopurinol and Sulphinpyrazone in Combination and with Allopurinol AloneAnnals of the Rheumatic Diseases, 1966
- Enzymatic and Metabolic Studies with AllopurinolAnnals of the Rheumatic Diseases, 1966
- Session I: Biochemistry and Metabolism: Effects of Alloplurnol in Relation to Purine BiosynthesisAnnals of the Rheumatic Diseases, 1966
- Metabolic studies of allopurinol, an inhibitor of xanthine oxidaseBiochemical Pharmacology, 1966
- Use of Allopurinol for Prevention and Control of Hyperuricemia in Patients with Neoplastic DiseaseNew England Journal of Medicine, 1966
- Allopurinol in the Treatment of GoutAnnals of Internal Medicine, 1966
- Prevention of Hyperuricemia in Leukemia and LymphomaJAMA, 1965
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- Tubular secretion of urate in the dogAmerican Journal of Physiology-Legacy Content, 1960
- ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTIONJournal of Biological Chemistry, 1945